Gara Jalqabaatti › Obesity › Maryland
Qorannoo klinikaalii Obesity Maryland keessatti
Qorannoo 54 Obesity f Maryland keessatti hirmaatuu jiru.
Magaalota Maryland keessatti
Takkalaa qorannoo (Ingiliffa)
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Annapolis Internal Medicine, LLC, Annapolis
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07684144Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Ascension Saint Agnes Heart Care, Baltimore
- MD Medical Research, Oxon Hill
- Velocity Clinical Research - Rockville, Rockville
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 45 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07037433New Heart Imaging Techniques to Evaluate Possible Heart Disease
- National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT01399385Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments
- National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 21 hanga 75 · Dubartoota · Haaromfame 02-Onk-2026 · NCT03288207Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention
- National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamooKaffaltii hirmaatootaaf ibsa
Umuriin 19 hanga 85 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT01927783Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
- National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 1 hanga 100 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT01143454A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Barry J. Reiner, MD LLC, Baltimore
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 8 hanga 18 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07253285A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Endo and Metabolic Consultants, Rockville
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07564414A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Ascension Saint Agnes Heart Care, Baltimore
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07595549Physical and Behavioral Traits of Overweight and Obese Adults
- National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT00428987Diabetes and Heart Disease Risk in Blacks
- National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT00001853A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Beltsville
- Research Site, Oxon Hill
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07776509Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Capital Digestive Care - Chevy Chase, Chevy Chase
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06937099A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Johns Hopkins Children's Center, Baltimore
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 6 hanga 17 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06672549Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Capital Digestive Care - Chevy Chase, Chevy Chase
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06937086A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Centennial Medical Group, Columbia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07392190A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Centennial Medical Group, Columbia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Flourish Research - Bowie, Bowie
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07369011A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- MedStar Good Samaritan Hospital, Baltimore
- MedStar Health Research Institute (MedStar Physician Based Research Network), Hyattsville
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07321886A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Beltsville
- Research Site, Lanham
- Research Site, Oxon Hill
- fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07784270Children s Growth and Behavior Study
- National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamooKaffaltii hirmaatootaaf ibsa
Umuriin 8 hanga 100 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT02390765Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate
- National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jira
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT06044935A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
- Research Site, Brooklyn
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 35 hanga 75 · Dubartoota · Haaromfame 17-Ful-2026 · NCT07013643Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study
- National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 12 hanga 25 · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06730113A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
- Research Site, Brooklyn
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 55 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07723833A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Bowie
- AURORA-2 Clinical Site, Rockville
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07743450Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Ascension Saint Agnes Heart Care, Baltimore
- Johns Hopkins University, Baltimore
- Metropolitan Cardiovascular Consultants LLC, Beltsville
- fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07037459A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Bowie
- AURORA-1 Clinical Site, Rockville
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07743463A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Centennial Medical Group, Columbia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07351058A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Baltimore VA Medical Center, Baltimore
- Johns Hopkins University School of Nursing, Baltimore
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07351045A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Silver Spring
Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 79 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07654374A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity
- PAREXEL Intl - EPCU-Baltimore, Baltimore
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 55 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07566390A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity.
- Research Site, Brooklyn
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07511205Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder
- Johns Hopkins University, Baltimore
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06847399A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Dermatology and Skin Cancer Specialists, LLC, Rockville
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT06857942Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Annapolis
- Kailera Clinical Site, Columbia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07284901Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Columbia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07284875A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Ascension Saint Agnes Heart Ca, Baltimore
- Mercy Medical Center, GI Research, Baltimore
- Flourish Research Bowie, Bowie
- fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT07567001Evaluation of Children With Endocrine and Metabolic-Related Conditions
- National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraQorannoo ilaalaa
3 Months – 100 Years · Saalaa hunda · Haaromfame 13-Hag-2026 · NCT02769975Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Silver Spring
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 79 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT07654361Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.